Novartis shares data on discontinued antibiotic research

Novartis AG (NYSE:NVS; SIX:NOVN) has included data from three discontinued antibacterial programs on a public data resource, the

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE